Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
about
The etiologic spectrum of head and neck squamous cell carcinoma in young patientsHPV Associated Head and Neck CancerRecent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerCorrelation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic reviewEpigenetic disregulation in oral cancerHuman papillomavirus and survival of patients with oropharyngeal cancer.p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinomaDecitabine rescues cisplatin resistance in head and neck squamous cell carcinomaDiagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.Clinical features and treatment strategy for HPV-related oropharyngeal cancer.Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counsellingCounseling the patient with potentially HPV-related newly diagnosed head and neck cancerPrognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review.Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma.Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway.The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature.Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neckA comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulationOpportunities and challenges facing biomarker development for personalized head and neck cancer treatment.HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.HPV-associated head and neck cancer: molecular and nano-scale markers for prognosis and therapeutic stratificationMolecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma.HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patientsA microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinomaPotentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosisLower MGMT expression predicts better prognosis in proneural-like glioblastomaOutcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.Human Papillomavirus Laboratory Testing: the Changing ParadigmHPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?Human papillomavirus prevalence and cell cycle related protein expression in tonsillar squamous cell carcinomas of korean patients with clinicopathologic analysis.
P2860
Q26741362-5F3AC6B9-FC75-412A-860C-7D8E18CD44A4Q26741386-82328614-07B7-4843-B611-4C884AF94870Q26782255-0DCC657A-E7C1-40A0-8FEA-2EE5CDE49EB9Q26824273-4F1A9FB8-88CE-49AF-A265-01ADC6E7D567Q27007004-82508D18-A631-4D89-AC3E-9874009C3908Q27851567-07939619-A354-47A3-BE85-7056DE2C2F84Q27853077-456E64EE-877B-4DE6-879C-8CCD094A6305Q28544907-A29475BB-94BB-42F6-93D8-17B27C78C684Q30241076-AFE81340-BDD4-47C5-8216-266BF0A2D1A6Q30249150-BC35014D-C68B-4956-82F2-44BD26FCFCCAQ33655046-46DE1897-68FF-4251-B765-B27BEB1005DCQ33757922-A0C0BBFA-0F5B-4B3F-A8B8-18652188D20AQ33908473-AC335AA0-88C6-49ED-8703-4F0FF4FD474BQ34193953-96CB4C38-324D-4FE9-A865-792AE7D01F85Q34433781-DF3EFE2E-AA91-421B-8463-F17F97E207D6Q34547715-6CE133EE-5A78-4B24-BCE0-686588E11B07Q34635004-60B6F4A8-90F9-4933-AFE7-37AD55B9535AQ34639763-D8437B03-A86E-42E7-A137-0BC88DEE3BADQ34993460-91CF84A6-9DD1-4BF9-90A9-DA74698F7EDBQ35048287-F13CE9CE-7EB1-407D-AEA8-09A005CBDF17Q35169110-714735FC-5D5D-4D54-8C3D-2418A6EB0F20Q35172674-5636BD97-67CB-4EF1-B81D-9AB23A705275Q35176423-CDB19E6A-5A59-4844-B3EC-685868AC0B59Q35673572-D25957B6-A738-4453-9006-50FDF147F582Q35678211-F22BF5C1-424C-4AEB-AF13-A98751D75825Q35740820-F63BEED1-B61C-4C67-9661-9B25D065C3FBQ35834637-C2B7E145-9123-492C-A72A-47AA166CA25FQ35925634-53B7711A-7D89-407D-A778-45610AED77DDQ35969807-2A135FDF-E4D9-42C1-B132-4C7C0DD11808Q36050759-05085A1F-1D04-49E2-9B93-4157CD38F244Q36088089-2A3A3570-DA10-40BA-BE09-7DEE928D6402Q36088094-29C51E4E-CC92-4310-B016-445A21EA82C3Q36287854-3E0EA328-4338-4374-9C3C-0C70FA630AF5Q36386860-7D16BB6D-4A50-4CA0-9E03-195D93AF2F74Q36400277-0FD1ECA8-1356-4F95-B888-1EB4E41035A7Q36492682-E4C1C626-916A-4EC8-B468-774814FB966CQ36621257-F6DA500B-034A-48C7-BE85-8BDADE31F14DQ36675236-C98FEB4A-7A82-41F4-A887-44B7D8B4297CQ36746765-D768D384-8AC7-4725-92C2-00E9F4792F4FQ36824384-7EDAE89B-F4D1-4E47-A57C-0C142977481A
P2860
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Comparative prognostic value o ...... pharyngeal squamous carcinoma.
@en
type
label
Comparative prognostic value o ...... pharyngeal squamous carcinoma.
@en
prefLabel
Comparative prognostic value o ...... pharyngeal squamous carcinoma.
@en
P2093
P50
P356
P1476
Comparative prognostic value o ...... opharyngeal squamous carcinoma
@en
P2093
Angela Hui
Bernard Cummings
Hisayuki Kato
Lillian Siu
Maura Gillison
Melania Pintilie
Patrick Gullane
P304
P356
10.1200/JCO.2009.23.1670
P407
P50
P577
2009-11-02T00:00:00Z